Hypercholesterolemia and coronary heart disease in the elderly: A meta-analysis

Annals of Epidemiology

Volumn 14, Issue 9, 2004, Pages 705-721

  Anum, Emmanuel A ^a   Adera, Tilahun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

CHD; Cholesterol; coronary heart disease; Elderly; EPESE; Established Population for the Epidemiologic Study of the Elderly; Hypercholesterolemia; Morbidity; Mortality; National Heart Lung and Blood Institute; NHANES; NHLBI; Risk

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PUBLISHING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; MEDLINE; MIDDLE AGED; RISK FACTORS;

EID: 4544353695     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2003.10.009     Document Type: Article

References (59)

1. Jónsson A., Sigvaldason H., Sigfússon N. Total cholesterol and mortality after age 80 years. [Correspondence] Lancet. 350:1997;9093
2. Weverling-Rijnsburger A.W.E., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., Westendorp R.G.J. Total cholesterol and risk of mortality in the oldest old. Lancet. 350:1997;1119-1123
3. Williams M.A. Cardiovascular risk-factor reduction in elderly patients with cardiac disease. Phys Ther. 76:1996;469-480
4. Manolio T.A., Pearson T.A., Wenger N.K., Barrett-Connor E., Payne G.H., Harlan W.R. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol. 2:1992;161-176
5. Harris T., Cook E.F., Kannel W.B., Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study. J Am Geriatr Soc. 36:1988;1023-1028
6. Kronmal R.A., Cain K.C., Zhan Ye, Omenn G.S. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med. 153:1993;1065-1073
7. D'Agostino R.B., Belanger A.J., Kannel W.B., Higgins M. Role of smoking in the U-shaped relation of cholesterol to mortality in men. The Framingham Study. Am J Epidemiol. 141:1995;822-827
8. Castelli W.P., Anderson K., Wilson P.W.F., Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 2:1992;23-28
9. Emond M.J., Zareba W. Prognostic value of cholesterol in women of different ages. J Womens Health. 6:1997;295-307
10. Benfante R., Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA. 263:1990;393-396
11. Benfante R., Yano K., Hwang L.-J., Curb J.D., Kagan A., Ross W. elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke. 25:1994;814-820
12. Reed D., Benfante R. Lipid and lipoprotein predictors of coronary heart disease in elderly men in the Honolulu Heart Program. Ann Epidemiol. 2:1992;29-34
13. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, et al., Lack of association between cholesterol and coronary heart disease mortality in persons older than 70 years. JAMA. 272:1994;1335-1340
14. Corti M., Guralnik J.M., Salive M.E., Harris T., Field T.S., Wallace R.B. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 274:1995;539-544
15. Corti M., Guralnik J.M., Salive M.E., Harris T., Ferrucci L., Glynn R.J., et al. clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 126:1997;753-760
16. Pekkanen J., Tervahauta M., Nissinen A., Karvonen M.J. Does the predictive value of baseline coronary risk factors change over a 30-year follow-up? Cardiology. 82:1993;181-190
17. Tervahauta M., Pekkanen J., Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finnish cohorts of the Seven Countries Study. J Am Coll Cardiol. 26:1995;1623-1629
18. Weijenberg M.P., Feskens J.M., Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up. The Zutphen Elder Study. Am J Epidemiol. 143:1996;151-158
19. Houterman S., Monique Verschuren W.M., Giampaoli S., Nissinen A., Feskens E.J.M., Menotti A., et al. Total but not high-density lipoprotein cholesterol is consistently associated with coronary heart disease mortality in elderly men in Finland, Italy, and the Netherlands. Epidemiology. 11:2000;327-332
20. Kornitzer M., Dramaix M., Beriot I., Lannoy M., Gheyssens H., Kittel F. Twenty-five-year mortality follow-up in the Belgian Bank Study. Cardiology. 82:1993;153-171
21. Goldbourt U., Yaari S., Medalie J.H. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology. 82:1993;100-121
22. Menotti A., Seccareccia F., Lanti M., Giampaoli S., Dima F. Time changes in predictability of coronary heart disease in an Italian aging population. Cardiology. 82:1993;172-180
23. Rubin S.M., Sidney S., Black D.M., Browner W.S., Hulley S.B., Cummings S.R. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med. 113:1990;916-920
24. Harris T., Kleinman J.C., Makuc D.M., Gillum R., Feldman J.J. Is weight loss a modifier of the cholesterol-heart disease relationship in older persons? Data from the NHANES I Epidemiologic Follow-up Study. Ann Epidemiol. 2:1992;35-41
25. Sorkin J.D., Andres R., Muller D.C., Baldwin H.L., Fleg J.L. Cholesterol as a risk factor for coronary heart disease in elderly men. The Baltimore Longitudinal Study of Aging. Ann Epidemiol. 2:1992;59-67
26. Barrett-Connor E. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study. Ann Epidemiol. 2:1992;77-83
27. Hames C.G., Rose K., Knowles M., Davis C.E., Tyroler H.A. Black-white comparisons of 20-year coronary heart disease mortality in the Evans County Heart Study. Cardiology. 82:1993;122-136
28. White A.D., Hames C.G., Tyroler H.A. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol. 2:1992;85-91
29. Keil J.E., Sutherland S.E., Knapp R.G., Gazes P.C. Serum cholesterol - risk factor for coronary disease in younger and older blacks and whites. The Charleston Heart Study, 1960-1988. Ann Epidemiol. 2:1992;93-99
30. Grover S.A., Palmer C.S., Coupal L. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch Intern Med. 154:1994;679-684
31. Stamler J., Dyer A.R., Shekelle R.B., Neaton J., Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: Findings from long-term follow-up of Chicago cohorts. Cardiology. 82:1993;191-222
32. Dyer A.R., Stamler J., Shekelle R.B. Serum cholesterol and mortality from coronary heart disease in young, middle-aged, and older men and women from three Chicago epidemiologic studies. Ann Epidemiol. 2:1992;51-57
33. Higgins M., Keller J.B. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh. Ann Epidemiol. 2:1992;69-76
34. Tyroler H.A., Ford C.E. Serum cholesterol and coronary heart disease risk in female and older hypertensives. The experience under usual community care in the Hypertension Detection and Follow-up Program. Ann Epidemiol. 2:1992;155-160
35. Frost P.H., Davis B.R., Burlando A.J., Curb D., Guthrie G.P. Jr., Isaacsohn J.L., et al. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation. 94:1996;2381-2388
36. Shipley M.J., Pocock S.J., Marmot M.G. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18-year follow up in Whitehall study. BMJ. 303:1991;89-92
37. Mangion D.M., Roy S.S. Serum lipids and coronary heart disease in British elderly. Postgrad Med J. 69:1993;609-614
38. Forette B., Tortrat D., Wolmark Y. Cholesterol as a risk factor for mortality in elderly women. Lancet. 1989;868-870
39. Psaty B.M., Furberg C.D., Kuller L.H., Bild D.E., Rautaharju P.M., Polak J.F., et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults. The Cardiovascular Health Study. Arch Intern Med. 159:1999;1339-1347
40. Menotti A. The relationship of total serum cholesterol to coronary heart disease in older men. The Italian Rural Areas of the Seven Countries Study. Ann Epidemiol. 2:1992;107-111
41. Larson M.G. Assessment of cardiovascular risk factors in the elderly: The Framingham Heart Study. Stat Med. 14:1995;1745-1756
42. Frank J.W., Reed D.M., Grove J.S. Will lowering population levels of serum cholesterol affect total mortality? J Clin Epidemiol. 45:1992;333-346
43. Simons L.A. Triglyceride levels and the risk of coronary artery disease: A view from Australia. Am J Cardiol. 70:1992;14H-18H
44. Kinosian B., Glick H., Garland G. Cholesterol and coronary heart disease: Predicting risks by levels and ratios. Ann Intern Med. 121:1994;641-647
45. Stober C., Clarke A., Mulvaney A., Harland J., Neithercut W.D. Cholesterol and lipoprotein (a) as risk factors for coronary heart disease in elderly subjects. Br J Biomed Sci. 51:1994;114-118
46. Emond M., Mock M.B., Davis K.B., Fisher L.D., Holmes D.R., Chaitman B.R., et al., participants in the Coronary Artery Surgery Study (CASS). Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation. 90:1994;2645-2657
47. Stamler J., Wentworth D., Neaton J.D., for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 256:1986;2823-2828
48. Langford H.G., Borhani N.O., Kass E.H., Payne G.H., Remington R.D., Stamler J., Writing Committee on behalf of the HDFP Cooperative Group. The Hypertension Detection and Follow-Up Program. Prev Med. 5:1976;207-215
49. Keys A., Taylor H.L., Blackburn H., Brozek J., Anderson J.T., Simonson E. Coronary heart disease among Minnesota business and professional men followed fifteen years. Circulation. 28:1963;381-395
50. Doyle J.T. Risk factors in coronary heart disease. New York State Journal of Medicine. 63:1963;1317-1320
51. Chapman J.M., Massey F.J. The interrelationship of serum cholesterol, hypertension, body weight, and risk of coronary disease. Results of the first ten years follow-up in the Los Angeles Heart Study. J Chronic Dis. 17:1964;933-949
52. Wilhelmsen L., Tibblin G., Werko L. A primary preventive study in Gothenburg, Sweden. Prev Med. 1:1972;153-160
53. Aronson M.K., Ooi W.L., Morgenstern H., Hafner A., Masur D., Crystal H., et al. Women, myocardial infarction, and dementia in the very old. Neurology. 40:1990;1102-1106
54. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet. 19:1955;251-253
55. Sacks F.M., Tonkin A.M., Shepherd J., Braunwald E., Cobbe S., Hawkins C.M., et al. Effects of Pravastatin on coronary disease events in subgroups defined by coronary risk factors. The Prospective Pravastatin Pooling Project. Circulation. 102:2000;1893-1900
56. Lemaitre R.N., Psaty B.M., Heckbert S.R., Kronmal R.A., Newman A.B., Burke G.L. Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors. Arch Intern Med. 162:2002;1395-1400
57. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., et al., for the AFCAPS/TexCAPS research group. Primary prevention of acute coronary events with Lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. JAMA. 279:(20):1998;1615-1622
58. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2506
59. LaRosa J.C. Dyslipidemia and coronary artery disease in the elderly. Clin Geriatr Med. 12:1996;33-40